Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Helen A. James is active.

Publication


Featured researches published by Helen A. James.


Clinical Cancer Research | 2010

Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.

Angela Stokes; Juho Joutsa; Risto Ala-aho; Mark Pitchers; Caroline J. Pennington; Craig Martin; Don J. Premachandra; Yasunori Okada; Juha Peltonen; Reidar Grénman; Helen A. James; Dylan R. Edwards; Veli-Matti Kähäri

Purpose: Head and neck squamous cell carcinomas (HNSCC) are characterized by high morbidity and mortality, largely due to the high invasive and metastatic potential of these tumors, high recurrence rates, and low treatment responses. Proteinases have been implicated in several aspects of tumor growth and metastasis in a broad range of tumors including HNSCC. Experimental Design: Comprehensive expression profiling of proteinases [matrix metalloproteinases (MMPs), A disintegrin and metalloproteinase (ADAMs), and ADAMs with thrombospondin motif (ADAMTSs)] and their inhibitors [tissue inhibitor of metalloproteinases (TIMPs)] was done using quantitative real-time reverse transcription-PCR analysis of a large cohort of tissue samples representing the tumor (n = 83), the invasive margin (n = 41), and the adjacent tissue (n = 41) from 83 HNSCC patients, along with normal tissue controls (n = 13), as well as cell lines established from tumors of 34 HNSCC patients. Results: The results show specifically elevated gene expression of several proteinases, including MMP1, MMP3, MMP10, and MMP13 within tumor tissue and peritumoral adjacent tissue. In addition, the results identify several novel HNSCC-associated proteinases, including ADAM8, ADAM9, ADAM17, ADAM28, ADAMTS1, ADAMTS8, and ADAMTS15. There were also significant differences in proteinase expression based on clinical parameters, i.e., tumor location, grade, and local invasion. MMP13 expression was significantly higher in large (>4 cm) locally invasive tumors (P < 0.05). MMP9 expression was significantly decreased in tumors with regional metastasis, whereas increased expression of ADAM8 was noted in the metastatic tumors (P < 0.001 for both). Conclusions: These findings suggest the HNSCC degradome as a valuable source of diagnostic, predictive, and prognostic molecular markers for these malignant tumors. Clin Cancer Res; 16(7); 2022–35. ©2010 AACR.


Bioscience Education | 2012

Exploring students? Initial reactions to the feedback they receive on coursework

Harriet Jones; Laura Hoppitt; Helen A. James; John Prendergast; Stephen M. Rutherford; Kay Yeoman; Mark R. Young

Abstract Understanding students’ reactions to their feedback to coursework is crucial in being able to deliver feedback which motivates them and helps them to do better. This study focused on undergraduate bioscience students on a variety of degree programmes, at three UK universities, across all years. A questionnaire was completed by students when first reading their feedback, thereby accessing their initial reactions to the comments they received. Focus groups assisted in the analysis of these initial reactions and also enabled discussion on how the students felt about their feedback. Our findings suggest that, although many students value feedback irrespective of their emotional response to it, others are clearly motivated or de-motivated by specific factors within the feedback that they receive. We suggest that this initial emotional reaction is fundamental to the student’s subsequent engagement with feedback, and that feedback that immediately de-motivates a student is likely to be of very limited value to the ongoing learning process. Recommendations to improve feedback include the need to offer positive, constructive comments, meaningful annotations and comments which justify the given mark.


Bioscience Education | 2011

Development and Evaluation of an Undergraduate Science Communication Module

Kay Yeoman; Helen A. James; Laura Bowater

Abstract This paper describes the design and evaluation of an undergraduate final year science communication module for the Science Faculty at the University of East Anglia. The module focuses specifically on science communication and aims to bring an understanding of how science is disseminated to the public. Students on the module are made aware of the models surrounding science communication and investigate how the science culture interfaces with the public. During the module they learn how to adapt science concepts for different audiences and how to talk confidently about science to a lay-audience. Student motivation for module choice centres on the acquisition of transferable skills and students develop these skills through designing, running and evaluating a public outreach event at a school or in a public area. These transferable skills acquired include communication, interaction with different organisations such as museums and science centres, developing understanding of both the needs of different audiences and the importance of time management. They also develop skills relating to self-reflection and how to use this as a tool for future self development. The majority of students completing the module go on to further study, either a PhD, MSc or teacher training. The module can be sustained in its present formed if capped at 40 students, however it is recognised that to increase cohort size, further investment of faculty time and resources would be required.


Expert Opinion on Investigational Drugs | 2000

Therapeutic potential of ribozymes in haematological disorders.

Helen A. James

Ribozymes are RNA molecules that possess the ability to cleave and thus destroy other RNA molecules. As a result of this ability, they are ideal specific agents to use against the messenger RNAs of important genes found to be linked with disease (of cellular and viral origin). This review will briefly describe the different types of ribozyme and the potential they have as therapeutic compounds against viruses, oncogenes and drug resistance in haematological settings. The latest news from the various Phase I and II ribozyme clinical trials is discussed, as is the potential for the ribozymes’ future as therapeutic agents.


Blood | 1998

The Therapeutic Potential of Ribozymes

Helen A. James; Ian Gibson


Leukemia | 1996

Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation

Helen A. James; Kenneth Ian Mills; Ian Gibson


Journal of Leukocyte Biology | 1999

The potential application of ribozymes for the treatment of hematological disorders

Helen A. James


Nature Medicine | 1995

Molecular DIY with hairpins and hammerheads

Saghir Akhtar; Helen A. James; Ian Gibson


Archive | 1997

Ribozymes: An Introduction

Helen A. James; Philip C. Turner


Archive | 2012

Using science fiction to teach science facts

Christine Cornea; Laura Bowater; Helen A. James; Richard P. Bowater

Collaboration


Dive into the Helen A. James's collaboration.

Top Co-Authors

Avatar

Harriet Jones

University of East Anglia

View shared research outputs
Top Co-Authors

Avatar

Ian Gibson

University of East Anglia

View shared research outputs
Top Co-Authors

Avatar

Kay Yeoman

University of East Anglia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura Bowater

University of East Anglia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ciara M Twomey

University of East Anglia

View shared research outputs
Researchain Logo
Decentralizing Knowledge